Protagenic Therapeutics, Inc.\new (PTIX) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US74365N1037

Price
0.47 USD
Market cap
854,418.18 USD
P/E (2026)
0.80
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
52.23 %
Return on assets (ROA)
37.48 %

Protagenic Therapeutics, Inc.\new financials

Fiscal year20252026
Revenue0.00 USD0.00 USD
Gross profit-37,715.00 USD–
Operating income-5.83 m USD-4.50 m USD
EBIT-3.59 m USD1.37 m USD
Net income-5.16 m USD1.37 m USD
Diluted EPS – continuing operations-0.67 USD0.59 USD

Full history since 1995, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Protagenic Therapeutics, Inc.\new

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.